John Skedros, MD
Orthopaedic Surgery · Salt Lake City, UTNPI 1972597730
Payments from drug & device makers
Across 38 payments — averaging $57.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- KCI USA, Inc.$1K
- Stryker$273
- Linvatec Corporation$171
- Pfizer$145
- Innovation Technologies Inc$119
- Johnson & Johnson$113
- plus $369 from 11 others
What the payments were for
- Consulting fees$1,00046%
- Food & beverage$1,18954%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| KCI USA, Inc. | 1 | $1,000 |
| Stryker | 7 | $273 |
| Linvatec Corporation | 1 | $171 |
| Pfizer | 10 | $145 |
| Innovation Technologies Inc | 2 | $119 |
| Johnson & Johnson | 2 | $113 |
| Zimmer Biomet | 1 | $69 |
| Medical Device Business Services, Inc. | 1 | $64 |
| Steris Corporation | 2 | $47 |
| Bioventus LLC | 3 | $44 |
| Biocomposites Inc | 2 | $41 |
| Active Medical, LLC | 1 | $38 |
| Integra Lifesciences Corporation | 1 | $17 |
| Anika Therapeutics, Inc. | 1 | $15 |
| Ferring Pharmaceuticals Inc. | 1 | $12 |
| Arthrosurface Incorporated | 1 | $12 |
| Portola Pharmaceuticals, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PREVENA$1,000
- BioBrace 23mm$171
- Irrisept$106
How this compares
$2,189 in reported general payments places this provider in the 35th percentile of 221 orthopaedic surgery providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 56 | $781 |
| Methocarbamol | 49 | $525 |
| Tramadol Hcl | 56 | $389 |
| Oxycodone Hcl | 25 | $233 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $218 |
| Ibuprofen | 12 | $144 |
| Ondansetron Hcl | 12 | $111 |
| Amoxicillin | 13 | $36 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Salt Lake City
- Aaron HofmannSalt Lake City$10.7M
- Jeremy GilillandSalt Lake City$3.3M
- Robert TashjianSalt Lake City$3M
- Jeffrey JacksonSalt Lake City$2.3M
- Brandon LawrenceSalt Lake City$1.9M
- Thomas HigginsSalt Lake City$1.6M
- Christopher MartinSalt Lake City$1.2M
- Christopher PeltSalt Lake City$436K
- Robert BurksSalt Lake City$355K
- Charles SaltzmanSalt Lake City$254K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.